PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions

Polish Journal of Pathology

Volumn 64, Issue 1, 2013, Pages 15-20

  Waniczek, Dariusz ^a,b   Śnietura, Mirosław ^c   Młynarczyk Liszka, Joanna ^c   Pigłowski, Wojciech ^c   Kopeć, Agnieszka ^c   Lange, Dariusz ^c   Rudzki, Marek ^a,b   Arendt, Jerzy ^a,b  

^a Chair and Department of General and Gastrointestinal Surgery   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Adenomatous polyp; Colorectal cancer; CRC; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

ADENOCARCINOMA; ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER STAGING; CELL NUCLEUS; COLON; COLORECTAL TUMOR; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; RECTUM; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADENOCARCINOMA; ADENOMATOUS POLYPS; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; COLON; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECTUM;

EID: 84876954020     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/PJP.2013.34598     Document Type: Article

References (24)

1. Didkowska J, Wojciechowska U, Zatonski W. Cancer in Poland in 2009. Warszawa 2011; 33.
2. Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008; 133: 403-414.
3. Pérez-Tenorio G, Alkhori L, Olsson B, et al. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res 2007; 13: 3577-84.
4. Xing M. Genetic alterations in the phosphatidylinositol-3 kinase/ Akt pathway in thyroid cancer. Thyroid 2010; 20: 697-706.
5. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-7.
6. Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 2011; 11: 289-301.
7. Tan M-H, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012; 18: 400-7.
8. Chang JG, Chen YJ, Perng LI, et al. Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract. Eur J Cancer 1999; 35: 647-51.
9. Danielsen SA, Lind GE, Bjoørnslett M, et al. Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instabilityand TP53 mutation-status. Hum Mutat 2008; 29: E252-262.
10. Karoui M, Tresallet C, Julie C, et al. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases. Br J Cancer 2004; 90: 1230-4.
11. Goel A, Arnold CN, Niedzwiecki D, et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 2004; 64: 3014-21.
12. Waniczek D, Snietura M, Piglowski W, et al. Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this location. Wspolczesna Onkol 2012; 16: 310-5.
13. Perren A, Weng LP, Boag AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999; 155: 1253-60.
14. Snietura M, Jaworska M, Mlynarczyk-Liszka J, et al. PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck. PLoS ONE 2012; 7: e33396.
15. Razis E, Briasoulis E, Vrettou E, et al. Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study. BMC Cancer 2008; 8: 234.
16. Wan X, Dennis AT, Obejero-Paz C, et al. Oxidative inactivation of the lipid phosphatase phosphatase and tensin homolog on chromosome ten (PTEN) as a novel mechanism of acquired long QT syndrome. J Biol Chem 2011; 286: 2843-2852.
17. Leslie NR, Foti M. Non-genomic loss of PTEN function in cancer: not in my genes. Trends Pharmacol Sci 2011; 32: 131-140.
18. Carracedo A, Alimonti A, Pandolfi PP. PTEN level in tumor suppression: how much is too little? Cancer Res 2011; 71: 629-633.
19. Colakoglu T, Yildirim S, Kayaselcuk F, et al. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am J Surg 2008; 195: 719-725.
20. Hsu CP, Kao TY, Chang WL, et al. Clinical significance of tumor suppressor PTEN in colorectal carcinoma. Eur J Surg Oncol 2011; 37: 140-147.
21. Lin MS, Huang JX, Chen WC, et al. Expression of PPAR-gamma and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology. Oncology Letters 2011; 2: 1219-1224.
22. Li X-H, Zheng H-C, Takahashi H, et al. PTEN expression and mutation in colorectal carcinomas. Oncol Rep 2009; 22: 757-764.
23. Sawai H, Yasuda A, Ochi N, et al. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 2008; 8: 56.
24. Jang K-S, Song YS, Jang S-H, et al. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. Histopathology 2010; 56: 229-239.